Global Oncology Anti-Cancer Drugs Market Research Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Oncology Anti-Cancer Drugs Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Oncology Anti-Cancer Drugs Market Overview:
Global Oncology Anti-Cancer Drugs Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Oncology Anti-Cancer Drugs involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Oncology Anti-Cancer Drugs Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Oncology Anti-Cancer Drugs market in 2020.
Global Oncology Anti-Cancer Drugs Market Segmentation
By Type, Oncology Anti-Cancer Drugs market has been segmented into:
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
By Application, Oncology Anti-Cancer Drugs market has been segmented into:
Blood Cancer (Leukaemia)
Breast Cancer
Gastrointestinal Cancer
Respiratory/Lung Cancer
Skin Cancer
Other Cancers
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Oncology Anti-Cancer Drugs market are:
Amgen
AstraZeneca
Roche Diagnostics
GlaxoSmithKline
Merck
Novartis
AbbVie
Sanofi
EIMC United Pharmaceuticals
Actavis
1. Market Overview of Oncology Anti-Cancer Drugs
1.1 Oncology Anti-Cancer Drugs Market Overview
1.1.1 Oncology Anti-Cancer Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Oncology Anti-Cancer Drugs Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Oncology Anti-Cancer Drugs Historic Market Size by Regions (2015-2020)
1.4 Oncology Anti-Cancer Drugs Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Oncology Anti-Cancer Drugs Sales Market by Type (2015-2026)
2.1 Global Oncology Anti-Cancer Drugs Historic Market Size by Type (2015-2020)
2.2 Global Oncology Anti-Cancer Drugs Forecasted Market Size by Type (2021-2026)
2.3 Chemotherapy
2.4 Targeted Therapy
2.5 Immunotherapy (Biologic Therapy)
2.6 Hormonal Therapy
2.7 Others
3. Covid-19 Impact Oncology Anti-Cancer Drugs Sales Market by Application (2015-2026)
3.1 Global Oncology Anti-Cancer Drugs Historic Market Size by Application (2015-2020)
3.2 Global Oncology Anti-Cancer Drugs Forecasted Market Size by Application (2021-2026)
3.3 Blood Cancer (Leukaemia)
3.4 Breast Cancer
3.5 Gastrointestinal Cancer
3.6 Respiratory/Lung Cancer
3.7 Skin Cancer
3.8 Other Cancers
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Oncology Anti-Cancer Drugs Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Oncology Anti-Cancer Drugs Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Oncology Anti-Cancer Drugs Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Oncology Anti-Cancer Drugs Business
5.1 Amgen
5.1.1 Amgen Company Profile
5.1.2 Amgen Oncology Anti-Cancer Drugs Product Specification
5.1.3 Amgen Oncology Anti-Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 AstraZeneca
5.2.1 AstraZeneca Company Profile
5.2.2 AstraZeneca Oncology Anti-Cancer Drugs Product Specification
5.2.3 AstraZeneca Oncology Anti-Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Roche Diagnostics
5.3.1 Roche Diagnostics Company Profile
5.3.2 Roche Diagnostics Oncology Anti-Cancer Drugs Product Specification
5.3.3 Roche Diagnostics Oncology Anti-Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 GlaxoSmithKline
5.4.1 GlaxoSmithKline Company Profile
5.4.2 GlaxoSmithKline Oncology Anti-Cancer Drugs Product Specification
5.4.3 GlaxoSmithKline Oncology Anti-Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Merck
5.5.1 Merck Company Profile
5.5.2 Merck Oncology Anti-Cancer Drugs Product Specification
5.5.3 Merck Oncology Anti-Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Novartis
5.6.1 Novartis Company Profile
5.6.2 Novartis Oncology Anti-Cancer Drugs Product Specification
5.6.3 Novartis Oncology Anti-Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 AbbVie
5.7.1 AbbVie Company Profile
5.7.2 AbbVie Oncology Anti-Cancer Drugs Product Specification
5.7.3 AbbVie Oncology Anti-Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Sanofi
5.8.1 Sanofi Company Profile
5.8.2 Sanofi Oncology Anti-Cancer Drugs Product Specification
5.8.3 Sanofi Oncology Anti-Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 EIMC United Pharmaceuticals
5.9.1 EIMC United Pharmaceuticals Company Profile
5.9.2 EIMC United Pharmaceuticals Oncology Anti-Cancer Drugs Product Specification
5.9.3 EIMC United Pharmaceuticals Oncology Anti-Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Actavis
5.10.1 Actavis Company Profile
5.10.2 Actavis Oncology Anti-Cancer Drugs Product Specification
5.10.3 Actavis Oncology Anti-Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Oncology Anti-Cancer Drugs Market Size (2015-2026)
6.2 North America Oncology Anti-Cancer Drugs Key Players in North America (2015-2020)
6.3 North America Oncology Anti-Cancer Drugs Market Size by Type (2015-2020)
6.4 North America Oncology Anti-Cancer Drugs Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Oncology Anti-Cancer Drugs Market Size (2015-2026)
7.2 East Asia Oncology Anti-Cancer Drugs Key Players in North America (2015-2020)
7.3 East Asia Oncology Anti-Cancer Drugs Market Size by Type (2015-2020)
7.4 East Asia Oncology Anti-Cancer Drugs Market Size by Application (2015-2020)
8. Europe
8.1 Europe Oncology Anti-Cancer Drugs Market Size (2015-2026)
8.2 Europe Oncology Anti-Cancer Drugs Key Players in North America (2015-2020)
8.3 Europe Oncology Anti-Cancer Drugs Market Size by Type (2015-2020)
8.4 Europe Oncology Anti-Cancer Drugs Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Oncology Anti-Cancer Drugs Market Size (2015-2026)
9.2 South Asia Oncology Anti-Cancer Drugs Key Players in North America (2015-2020)
9.3 South Asia Oncology Anti-Cancer Drugs Market Size by Type (2015-2020)
9.4 South Asia Oncology Anti-Cancer Drugs Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Oncology Anti-Cancer Drugs Market Size (2015-2026)
10.2 Southeast Asia Oncology Anti-Cancer Drugs Key Players in North America (2015-2020)
10.3 Southeast Asia Oncology Anti-Cancer Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Oncology Anti-Cancer Drugs Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Oncology Anti-Cancer Drugs Market Size (2015-2026)
11.2 Middle East Oncology Anti-Cancer Drugs Key Players in North America (2015-2020)
11.3 Middle East Oncology Anti-Cancer Drugs Market Size by Type (2015-2020)
11.4 Middle East Oncology Anti-Cancer Drugs Market Size by Application (2015-2020)
12. Africa
12.1 Africa Oncology Anti-Cancer Drugs Market Size (2015-2026)
12.2 Africa Oncology Anti-Cancer Drugs Key Players in North America (2015-2020)
12.3 Africa Oncology Anti-Cancer Drugs Market Size by Type (2015-2020)
12.4 Africa Oncology Anti-Cancer Drugs Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Oncology Anti-Cancer Drugs Market Size (2015-2026)
13.2 Oceania Oncology Anti-Cancer Drugs Key Players in North America (2015-2020)
13.3 Oceania Oncology Anti-Cancer Drugs Market Size by Type (2015-2020)
13.4 Oceania Oncology Anti-Cancer Drugs Market Size by Application (2015-2020)
14. South America
14.1 South America Oncology Anti-Cancer Drugs Market Size (2015-2026)
14.2 South America Oncology Anti-Cancer Drugs Key Players in North America (2015-2020)
14.3 South America Oncology Anti-Cancer Drugs Market Size by Type (2015-2020)
14.4 South America Oncology Anti-Cancer Drugs Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Oncology Anti-Cancer Drugs Market Size (2015-2026)
15.2 Rest of the World Oncology Anti-Cancer Drugs Key Players in North America (2015-2020)
15.3 Rest of the World Oncology Anti-Cancer Drugs Market Size by Type (2015-2020)
15.4 Rest of the World Oncology Anti-Cancer Drugs Market Size by Application (2015-2020)
16 Oncology Anti-Cancer Drugs Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Oncology Anti Cancer Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|